Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT07445451 2026-03-03

TURBT

Phase NA Completed

93 enrolled

Genitourinary

Urinary Bladder Neoplasms, Pain, Postoperative

NCT07125924 2025-08-15

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

Phase NA Not yet recruiting

54 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03834493 2025-07-18

KEYNOTE-641

Phase 3 Active not recruiting

1,244 enrolled 21 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Phase 3 Completed

1,030 enrolled 24 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

Phase 3 Completed

806 enrolled 32 charts

Genitourinary

Prostatic Neoplasms

NCT06696794 2025-02-19

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

Phase 3 Recruiting

180 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Phase 3 Terminated

81 enrolled 19 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT06146777 2023-11-29

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

Phase 3 Not yet recruiting

468 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT03359239 2023-05-16

Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

Phase 1 Completed

10 enrolled

Genitourinary

Urologic Neoplasms

NCT01869413 2022-10-04

TACT

Phase 2/3 Completed

354 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03062059 2022-04-14

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

Phase 2 Unknown

134 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT03232125 2020-08-25

Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position

Phase NA Completed

54 enrolled

Genitourinary

Prostatic Neoplasms

NCT02833038 2019-04-05

Effect of Intravenous Magnesium During Robot Assisted Prostatectomy

Phase NA Completed

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT03529643 2018-09-13

Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALP

Phase NA Completed

128 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

KEYNOTE-564

TURBT

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

KEYNOTE-641

KEYNOTE-921

ERA 223

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

KEYNOTE-921

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

TACT

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position

Effect of Intravenous Magnesium During Robot Assisted Prostatectomy

Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALP